Here, together with anti-CTLA-4 and anti-PD-1 Abs, anti-CD73 Abs showed significant efficacy in stimulating tumor immunity in several tumor models including colon, prostate, subcutaneous tumors, and breast cancer (94). Here, NT5E is linked to breast carcinoma.